← Evidence map

ArticleTrials2026

ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD).

Friederike Ufer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD). | OpenQuestion